Last reviewed · How we verify

NCT04829812: COMPAD2

Medical Compression in Patients With Chronic Wound and Peripheral Arterial Disease

Completed Last updated 12 January 2022
What this trial tests

trial in Peripheral Arterial Disease in 500 participants. Completed in 21 December 2021.

Timeline
15 March 2021
Primary endpoint
1 December 2021
21 December 2021

Quick facts

Lead sponsorUniversity Hospital, Montpellier
StatusCompleted
Study typeOBSERVATIONAL
Enrollment500
Start date15 March 2021
Primary completion1 December 2021
Estimated completion21 December 2021
Sites1 location across France

Conditions studied

Sponsor

University Hospital, Montpellier

Who can join

18 and older, any sex, with Peripheral Arterial Disease or Chronic Wound of the Lower Limb (Leg Ulcer or Foot Ulcer). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Real-life practice survey of vascular specialist in France caring for patients with chronic wound for which compression treatment would be indicated and arterial disease of the lower limbs

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Peripheral Arterial Disease

Currently open trials in the same condition.

Other University Hospital, Montpellier trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04829812.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing